|
|
||||||||
Division of Nuclear Medicine, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California
Laboratory of Structural Biology and Molecular Medicine, University of California, Los Angeles, California
Correspondence: For correspondence or reprints contact: Johannes Czernin, MD, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California 90095-1735.
ABSTRACT
Stress testing with intravenous injection of dipyridamole is frequently used for noninvasive detection of coronary artery disease (CAD) with PET or SPECT. Dietary intake of caffeinated food, beverages or medication might alter both resting and dipyridamole-induced hyperemic blood flow, thereby compromising the diagnostic sensitivity of dipyridamole stress testing. Methods: To quantify the effect on myocardial blood flow at rest and during intravenous injection of dipyridamole, 12 healthy volunteers (mean age 27 ± 6 yr) with low risk for CAD were studied with dynamic PET and a tracer kinetic model for 13N-ammonia after 24 hr of caffeine abstinence and after caffeine intake. Results: Caffeine tended to increase the rate pressure product from 6873 ± 1494 to 7566 ± 1102 (p = 0.051), whereas resting myocardial blood flow remained unchanged (0.61 ± 0.13 versus 0.58 ± 0.07 ml/g/min, p = ns). The heart rate response to dipyridamole was inversely related to serum caffeine levels. Hyperemic blood flow (2.01 ± 0.46 versus 1.31 ± 0.0.38 ml/g/min; p < 0.001) and flow reserve (3.4 ± 0.8 versus 2.3 ± 0.7; p < 0.001) were inversely related to the caffeine dose. Coronary vascular resistance at rest tended to increase (132 ± 32 versus 147 ± 25 mmHg/ml/g/min; p = 0.06), whereas minimal coronary vascular resistance was significantly higher after caffeine (41 ± 9 to 69 ± 25mmHg/ml/g/min; p < 0.01). Conclusion: Caffeine intake alters the coronary vasomotor tone at rest, which might lower the threshold for ischemic eventsin patients with CAD. It reduces hyperemic blood flow and flow reserve and the dipyridamole-induced increase in heart rate in a dose-dependent fashion. These findings emphasize the importance of carefully screening patients for intake of caffeinated food, beverages or medication prior to dipyridamole stress testing.
Key Words: positron emission tomography myocardial blood flow caffeine dipyridamole
This article has been cited by other articles:
![]() |
M. M. Madsen, H. M. Sondergaard, M. Bottcher, N. H. Buus, O. Schmitz, H. E. Botker, and T. T. Nielsen Impact of Type 2 Diabetes on Nitric Oxide and Adrenergic Modulation of Myocardial Perfusion Diabetes, February 1, 2007; 56(2): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S C Chua, R H Ganatra, D J Green, and A M Groves Nuclear cardiology: myocardial perfusion imaging with SPECT and PET Imaging, September 1, 2006; 18(3): 166 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Zoghbi, T. Htay, R. Aqel, L. Blackmon, J. Heo, and A. E. Iskandrian Effect of Caffeine on Ischemia Detection by Adenosine Single-Photon Emission Computed Tomography Perfusion Imaging J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Namdar, P. Koepfli, R. Grathwohl, P. T. Siegrist, M. Klainguti, T. Schepis, R. Delaloye, C. A. Wyss, S. P. Fleischmann, O. Gaemperli, et al. Caffeine Decreases Exercise-Induced Myocardial Flow Reserve J. Am. Coll. Cardiol., January 17, 2006; 47(2): 405 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kubo, E. Tadamura, H. Toyoda, M. Mamede, M. Yamamuro, Y. Magata, T. Mukai, H. Kitano, N. Tamaki, and J. Konishi Effect of Caffeine Intake on Myocardial Hyperemic Flow Induced by Adenosine Triphosphate and Dipyridamole J. Nucl. Med., May 1, 2004; 45(5): 730 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Anagnostopoulos, M Harbinson, A Kelion, K Kundley, C Y Loong, A Notghi, E Reyes, W Tindale, and S R Underwood Procedure guidelines for radionuclide myocardial perfusion imaging Heart, January 1, 2004; 90(90001): i1 - 10. [Full Text] [PDF] |
||||
![]() |
L. M. Riou, M. Ruiz, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, G. A. Beller, and D. K. Glover Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A2A-receptor-mediated coronary vasodilation J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1687 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. M. Zheng and R. C. Williams Serum Caffeine Levels After 24-Hour Abstention: Clinical Implications on Dipyridamole 201Tl Myocardial Perfusion Imaging J. Nucl. Med. Technol., September 1, 2002; 30(3): 123 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bottcher, M. M. Madsen, J. Refsgaard, N. H. Buus, I. Dorup, T. T. Nielsen, and K. Sorensen Peripheral Flow Response to Transient Arterial Forearm Occlusion Does Not Reflect Myocardial Perfusion Reserve Circulation, February 27, 2001; 103(8): 1109 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Nielsen, M. Bottcher, T. Toftegaard Nielsen, A. K. Pedersen, and H. R. Andersen Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing--effect of pacing mode and rate J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1453 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bottcher, H. E. Botker, H. Sonne, T. T. Nielsen, and J. Czernin Endothelium-Dependent and -Independent Perfusion Reserve and the Effect of L-arginine on Myocardial Perfusion in Patients With Syndrome X Circulation, April 13, 1999; 99(14): 1795 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Campisi, J. Czernin, H. Schoder, J. W. Sayre, F. D. Marengo, M. E. Phelps, and H. R. Schelbert Effects of Long-term Smoking on Myocardial Blood Flow, Coronary Vasomotion, and Vasodilator Capacity Circulation, July 14, 1998; 98(2): 119 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Yokoyama, T. Ohtake, S.-i. Momomura, K. Yonekura, N. Kobayakawa, T. Aoyagi, S. Sugiura, Y. Sasaki, and M. Omata Altered Myocardial Vasodilatation in Patients With Hypertriglyceridemia in Anatomically Normal Coronary Arteries Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 294 - 299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |